|Indiana University of Pennsylvania, Bachelor of Science (B.S.)||2012|
Bonnie Anderson is the Co - Founder & Chief Executive Officer at Veracyte Inc.
Her career spans nearly 30 years in regulated diagnostics and life science markets where she has led both early-stage businesses, as well as mature, global enterprises. Under Ms. Anderson’s leadership, Veracyte has achieved significant commercialization milestones since its formation in 2008.
These include the launch of its first product; national Medicare coverage for its gene expression test; a global co-promotion partnership with Genzyme, a Sanofi company; and publication of strong clinical validation study results in the New England Journal of Medicine.
Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter, including heading the company’s global cellular analysis franchise in hematology and flow cytometry.
As Vice President of the intrapreneurial start-up Immunomics Operations, she successfully positioned the company’s novel MHC tetramer technology as a vehicle for drug and vaccine developers to monitor ex-vivo immune response.
She currently serves as a member of the Board of Trustees of Keck Graduate Institute of Applied Life Sciences.
She graduated from Indiana University of Pennsylvania with a Bachelors of Science degree in Medical Technology.
In 2012 was honored as a Distinguished Alumni Award recipient.